Emergence of methicillin-resistant Staphylococcus pseudintermedius in Switzerland: three cases of urinary tract infections in cats

Schweizer Archiv für Tierheilkunde
K WettsteinVincent Perreten

Abstract

Methicillin resistance has emerged in clinical isolates of Staphylococcus pseudintermedius from cats in Switzerland. Three cats suffering from urinary tract infections were infected with methicillin-resistant S. pseudintermedius (MRSP). Phenotypic and genotypic characterization of the resistance profile showed that the isolates displayed resistance to all beta-lactams and cephalosporins (blaZ, mecA), fluoroquinolones, tetracyclines [tet(K)], macrolides, lincosamides and streprogramins B [erm(B)], chloramphenicol (catpC221), trimethoprim [dfr(G)] and the aminoglycosides gentamicin [aac(6')-Ie-aph(2')-Ia], kanamycin and neomycin [aph(3')-III] and streptomycin [ant(6)-Ia]. They also harbor the leukocidin gene lukS-I. MRSP represents a new challenge for antibiotic therapy and this zoonotic bacteria may rapidly spread to animals and humans.

Citations

Sep 21, 2011·The Journal of Antimicrobial Chemotherapy·Engeline van DuijkerenUNKNOWN Scientific Advisory Group on Antimicrobials (SAGAM)
Nov 2, 2012·Journal of Clinical Microbiology·S M SolymanS A Kania
Jul 5, 2011·Polish Journal of Veterinary Sciences·D ChrobakM Binek
Mar 17, 2010·Journal of Veterinary Emergency and Critical Care·Leah A Cohn, John R Middleton
Apr 23, 2016·Veterinary and Comparative Orthopaedics and Traumatology : V.C.O.T·Mohammed A AzabJoshua B Daniels
Dec 24, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S BörjessonU Grönlund
Jun 12, 2012·Veterinary Dermatology·Kristina Kadlec, Stefan Schwarz
Sep 10, 2014·Veterinary Surgery : VS·Ryen TurkJ Scott Weese
Sep 25, 2021·Scientific Reports·K BierowiecA Gamian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.